Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
diagnostics
earnings
startups
abbvie
adaptive biotechnologies
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
arvinas
asia
baidu
batten disease
bayer
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
china
christine mcsherry
chuck schumer
clinial trials
crispr therapeutics
cystic fibrosis
dan chevallard
darolutamide
deals
detroit blog main
detroit top stories
diroximel fumarate
doctor anywhere
What
company
4
×
revenue
4
×
expectations
acquisitions
adaptive
advertising
albert
anywhere’s
asia
baidu
beat
biggest
bio
biotechnologies
blowback
bourla
business
ceo
china’s
continues
costs
covid
crispr
doctor
dominant
drove
drug
expenses
fight
financial
fiscal
following
forecast
future
fy
glaxosmithkline
government
healthtech
immune
imports
Language
unset
unknown
Current search:
revenue
×
company
×
@techinasia.com
10 months ago
Doctor Anywhere’s FY 2022 revenue up 62%, losses widen to $33m
@geekwire.com
3 years ago
Adaptive Biotechnologies posts $26.3M in Q3 revenue, inks partnership with GlaxoSmithKline
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@techcrunch.com
7 years ago
Baidu slashes revenue forecast as government probes its medical advertising business